Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical Ownership Summary

Takeda Pharmaceutical is owned by 4.85% institutional investors, 0.01% insiders, and 95.14% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.83% of TAK shares. Capital Group American Mutual Comp is the top mutual fund, with 0.41% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Takeda Pharmaceutical	4.85%	0.01%	95.14%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Specialty & Generic Drug Manufacturers Stocks	43.51%	11.55%	44.95%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital research global investors	13.30M	0.83%	$205.55M
Morgan stanley	4.99M	0.32%	$64.53M
Goldman sachs group	4.63M	0.29%	$61.28M
Brandes investment partners, lp	3.71M	0.23%	$57.39M
Blackrock funding, inc. /de	3.55M	0.22%	$54.90M
Fmr	3.39M	0.21%	$44.83M
First trust advisors lp	3.24M	0.20%	$42.91M
Renaissance	3.08M	0.19%	$40.77M
Adage capital partners gp	2.53M	0.16%	$39.17M
Ubs group	1.66M	0.10%	$22.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Managed asset portfolios	1.49M	2.99%	$23.02M
Clean yield group	275.02K	1.27%	$4.25M
Legacy wealth asset management	164.78K	0.65%	$2.55M
Summit global investments	729.20K	0.60%	$9.65M
Gold investment management	100.05K	0.58%	$1.54M
Brandes investment partners, lp	3.71M	0.52%	$57.39M
Arjuna capital	55.22K	0.23%	$853.73K
Bridgefront capital	48.48K	0.20%	$749.55K
Cowen and company	530.60K	0.19%	$6.87M
Crossmark global	727.19K	0.18%	$11.24M

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	1.66M	0.00%	1.59M
Blackrock funding, inc. /de	3.55M	0.00%	920.04K
Cowen and company	530.60K	0.19%	530.60K
Bnp paribas arbitrage, snc	500.68K	0.00%	497.46K
Fmr	3.39M	0.00%	477.37K

Top Sellers

Holder	Shares	% Assets	Change
Mondrian investment partners	1.54K	0.00%	-5.09M
Millennium management	246.66K	0.00%	-1.75M
Soleus capital management	-	-	-1.18M
Adage capital partners gp	2.53M	0.07%	-899.30K
Van eck associates	1.33M	0.02%	-840.95K

New Positions

Holder	Shares	% Assets	Change	Value
Cowen and company	530.60K	0.19%	530.60K	$6.87M
Vise	80.64K	0.05%	80.64K	$1.25M
Arjuna capital	55.22K	0.23%	55.22K	$853.73K
Wetherby asset management	44.87K	0.03%	44.87K	$693.66K
Walleye capital	31.78K	0.00%	31.78K	$491.32K

Sold Out

Holder	Change
Transamerica financial advisors	-1.00
Northwest financial advisors	-1.00
Point72 asia (singapore) pte.	-3.00
West branch capital	-3.00
Sugarloaf wealth management	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	309	-0.32%	77,823,025	9.47%	4	24.04%	185	9.47%	63	-29.21%
Mar 31, 2025	3	-98.99%	4,050,360	-94.38%	-	1.24%	2	-98.64%	1	-98.94%
Dec 31, 2024	182	-40.13%	33,476,783	-56.07%	2	9.19%	84	-48.47%	58	-31.76%
Sep 30, 2024	301	5.24%	76,190,360	5.65%	4	23.28%	160	33.33%	85	-16.67%
Jun 30, 2024	285	-10.94%	72,112,827	-7.86%	4	18.47%	120	-25.93%	101	21.69%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Capital Group American Mutual Comp	12.89M	0.41%	-
American Funds American Mutual A	12.89M	0.41%	-
First Trust Value Line® Dividend ETF	2.69M	0.09%	-3.37K
VanEck Pharmaceutical ETF	922.88K	0.03%	-8.47K
Mondrian Int Eq Delivered Strategy	816.00K	0.03%	-1.77M
MAP Global Equity Composite	716.61K	0.02%	6.57K
Steward International Enhanced Index I	651.53K	0.02%	315.75K
Steward Values Enhanced International I	651.53K	0.02%	-
Capital Group American Mutual Trust U0	407.53K	0.01%	94.57K
MAP Global Balanced Composite	391.63K	0.01%	4.24K

Insider Transactions Trends

Date	Buy	Sell
2022 Q4	-	-

TAK Ownership FAQ

Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 4.85%, followed by 0.01% insiders and 95.14% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (13.3M shares, 0.83%), Morgan stanley (4.99M shares, 0.32%), and Goldman sachs group (4.63M shares, 0.29%). Together, they hold 1.44% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Takeda Pharmaceutical.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 2.99% of its assets in 1.49M Takeda Pharmaceutical shares, valued at 23.02M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

Capital Group American Mutual Comp is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.41% of its total shares outstanding invested in 12.89M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools